1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Strategy

Health Insurance Offering OTC Benefits Trims Spending For Consumers, Providers In CHPA Study

 
• By Eileen Francis

Study assessed benefits in 2020 for around 30,000 clients in regional Medicate Advantage plan with OTC drug benefits. Data also show consumers in the study who opted for OTC drug benefits are more likely to need to pay for medical costs.

Including OTC drug benefits in health care plans may reduce spending by consumers and their insurers for medical care and prescription drugs, according to a study commissioned by the Consumer Healthcare Products Association.

Data from Medicare Advantage (MA) program clients also show that consumers who opt for health insurance with OTC drug benefits...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

People On The Move: Appointments At Haleon, Nestlé, Cornerstone

 
• By Tom Gallen

A round up of the latest European health & wellness moves: Haleon names Lauder's Haney as R&D chief; Nestle nominates Isla for board chair; Cornerstone appoints Stada's Ed Round.

Navamedic Adds OTC Naloxone With DNE Pharma Acquisition

 
• By Tom Gallen

Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.

Acquisitions Help Spain’s Uriach Grow Sales By More Than 50%

 
• By Tom Gallen

European consumer health player Uriach records sales approaching €500m in 2024 after completing acquisitions which took the firm into new markets.

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By Tom Gallen

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

More from Business

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By Tom Gallen

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

TheraBreath ‘Guarantee Better’ Claim Serious, Not Puffery With Founder Prominent In Advertising

 
• By Malcolm Spicer

Challenged advertising, which appeared in a TV commercial, in-store displays and advertising on social media, included express claims “It’s a better mouthwash. I guarantee it.” and “I guarantee it. – ‘Dr. Harold Katz.’”